ALX Oncology Holdings Inc.Profile
|
|
Share Price & Volume
| Previous Close | $2.13 | |
| Open | +2.58% | $2.19 |
| Day Low | +0.23% | $2.14 |
| Day High | +10.72% | $2.36 |
| 52-Week Low | -81.03% | $0.40 |
| 52-Week High | +24.88% | $2.66 |
| Day Volume | 1,223,833 | |
| Average Volume | 545,736 | |
| EPS (TTM) | -$1.90 | |
| P/E (TTM) | -1.16x | |
| FWD P/E (NTM) | - | |
| Next Earnings Date | May 7, 2026 |
| Market Cap | 119,842,092 | |
| Shares Outstanding (Millions) | 54,227,191 | |
| Dividend | - | |
| Beta | 0.50 | |
| ROE | -1.28% | |
| ROA | -0.51% |
Analyst Ratings and Price Targets
Current:
$2.21
Average:
$4.00
(+81.00%)
Low:
$4.00
(+81.00%)
High:
$4.00
(+81.00%)
| Piper Sandler | Maintains | Overweight | $4.00 | +81.00% | Feb 5, 2026 |
Headquarters
South San Francisco, CA, USA
Sector
Industry
# of Employees
65